| 233.07 Data as of May 22 | +1.74 / +0.75%Today’s Change | 126.39 Today|||52-Week Range 238.83 | +59.23% Year-to-Date |
| Cramer's 'Mad Money' Recap: Ignore the Fed May 22 / TheStreet.com | AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com |
| Additional Patent for Acorda's Ampyra - Analyst Blog May 22 / Zacks.com | Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard May 15 / TheStreet.com |
| This Is Incredibly Bullish Behavior May 22 / TheStreet.com | Isis Gets $3.5M Milestone Payment - Analyst Blog May 14 / Zacks.com |
| Biogen Idec Stock Hits New 52-Week High (BIIB) May 22 / TheStreet.com | Elan seeks to weaken hostile bid with $1bn Theravance deal May 13 / FT.com |
| Positive Data on Novo Nordisk's N9-GP - Analyst Blog May 21 / Zacks.com | Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog May 08 / Zacks.com |
| Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com |